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Eﬀ ect of a fall in malaria transmission on morbidity and 
mortality in Kiliﬁ , Kenya
Wendy P O’Meara, Phillip Bejon, Tabitha W Mwangi, Emelda A Okiro, Norbert Peshu, Robert W Snow, Charles R J C Newton, Kevin Marsh
Summary
Background As eﬀ orts to control malaria are expanded across the world, understanding the role of transmission 
intensity in determining the burden of clinical malaria is crucial to the prediction and measurement of the eﬀ ectiveness 
of interventions to reduce transmission. Furthermore, studies comparing several endemic sites led to speculation 
that as transmission decreases morbidity and mortality caused by severe malaria might increase. We aimed to assess 
the epidemiological characteristics of malaria in Kiliﬁ , Kenya, during a period of decreasing transmission intensity. 
Methods We analyse 18 years (1990–2007) of surveillance data from a paediatric ward in a malaria-endemic region of 
Kenya. The hospital has a catchment area of 250 000 people. Clinical data and blood-ﬁ lm results for more than 
61 000 admissions are reported.
Findings Hospital admissions for malaria decreased from 18·43 per 1000 children in 2003 to 3·42 in 2007. Over 
18 years of surveillance, the incidence of cerebral malaria initially increased; however, malaria mortality decreased 
overall because of a decrease in incidence of severe malarial anaemia since 1997 (4·75 to 0·37 per 1000 children) and 
improved survival among children admitted with non-severe malaria. Parasite prevalence, the mean age of children 
admitted with malaria, and the proportion of children with cerebral malaria began to change 10 years before 
hospitalisation for malaria started to fall.
Interpretation Sustained reduction in exposure to infection leads to changes in mean age and presentation of disease 
similar to those described in multisite studies. Changes in transmission might not lead to immediate reductions in 
incidence of clinical disease. However, longitudinal data do not indicate that reductions in transmission intensity lead 
to transient increases in morbidity and mortality.
Funding Wellcome Trust, Kenya Medical Research Institute.
Introduction
Malaria transmission intensity across Africa ranges from 
unstable epidemic transmission to high perennial 
transmission and can be characterised by 100-fold 
diﬀ erences in entomological measures of transmission.1 
The clinical epidemiology of malaria under diﬀ erent 
conditions of transmission has been described in 
ecological comparisons between sites.2–8 Consistent 
diﬀ erences have been shown in the presentation of severe 
malaria and the age of people aﬀ ected. Under conditions 
of high transmission, the burden of disease rests 
disproportionately on very young children and severe 
disease is most commonly malarial anaemia. Immunity 
to malaria is acquired quickly, and severe malaria is rarely 
seen in children older than 5 years. With lower 
transmission, the burden of disease is distributed 
throughout childhood, and the proportion of children who 
develop cerebral malaria—characterised by impaired 
consciousness, seizures, and coma—increases.
The relation between transmission intensity and the 
overall incidence of disease is more complex. The 
incidence of disease seems to be insensitive to diﬀ erences 
in transmission over a wide range of intermediate values, 
decreasing only when transmission drops below a 
threshold value.2,9,10 Disease incidence might  also decrease 
slightly under conditions of very high transmission.
The higher mean age of children with malaria in areas 
of low transmission, coupled with an increase in case 
fatality with age after infancy (caused partly by the higher 
incidence of cerebral malaria in older children), led to 
speculation of a possible increase in mortality as 
transmission decreases. Analysis of mortality data from 
multiple endemic areas indicates that mortality either 
increases linearly with transmission, reaches a plateau at 
moderate transmission, or possibly reaches a peak at 
moderate transmission and decreases slightly at very 
high transmission.11–13 Whichever scenario is true, these 
observations apply to communities observed for short 
intervals with little or no change in transmission. Where 
transmission is falling, children will have acquired 
immunity under conditions of higher transmission in 
preceding years. Longitudinal surveillance in a single site 
is therefore essential for predicting and monitoring the 
eﬀ ects of malaria control measures designed to reduce 
exposure to infection.
Okiro and colleagues described a recent downward 
trend of hospital admission for malaria in three 
contiguous districts of coastal Kenya.14 Intensive 
community surveillance in a small, well-deﬁ ned 
population in one of those districts showed that 
signiﬁ cant reductions in exposure to infection preceded 
a decrease in admissions.15 We now analyse 18 years of 
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detailed hospital surveillance data in a large malaria 
endemic area of the Kenyan coast. We describe changes 
in incidence of, and age of patients with, severe malaria 
and test the hypothesis that changes in transmission 
cause changes in the proportion and incidence of the 
severe forms of disease.
Methods
Study area and population
Kiliﬁ  district lies on the coast of Kenya, stretches along 
65 km of coastline, extends 90 km inland from the coast 
at the widest point, and covers diverse ecological zones. 
The district is subdivided into 36 administrative units 
known as locations. Two-thirds of the population live in 
14 locations surrounding Kiliﬁ  District Hospital, from 
which 80% of paediatric admissions come. In 2002, these 
14 locations were incorporated into a demographic 
surveillance site; comprising the catchment area for Kiliﬁ  
District Hospital, we refer to them as the study area. Kiliﬁ  
District Hospital is located centrally within the district 
and serves as the ﬁ rst referral centre for patients requiring 
hospitalisation. The hospital operates a paediatric ward 
with 35 beds and a smaller paediatric high-dependency 
unit. Children up to 14 years of age are admitted to the 
paediatric ward, although 94% of children admitted are 
less than 8 years old. 
About 250 000 people currently live in the study area, 
most living oﬀ  subsistence farming and ﬁ shing. Malaria 
is endemic, and transmission increases after the long 
rains from April to June and the short rains from October 
to November each year. The main malaria vectors are 
Anopheles gambiae sensu lato, with minor contributions 
from Anopheles funestus.16 The annual entomological 
inoculation rate varied across the study area from less 
than 0·1 to 60 in the mid-1990s.16,17
Bednet use also varies across the study area. In the 
early 1990s, coverage was estimated to be less than 6%.18 
A trial of insecticide-treated nets was started in part of 
northern Kiliﬁ  in June, 1993, and insecticide treated nets 
were distributed to residents in a deﬁ ned geographical 
area representing about 30% of the population,19 although 
use in other areas remained low.20 In 2005, insecticide-
treated nets became available through government clinics 
at highly subsidised cost, and in September, 2006, a free 
distribution campaign by the District Health Management 
Team increased coverage across Kiliﬁ  district from 
about 0·25 to 0·5 insecticide-treated nets per person.14
Population 
<14 years
Admissions Slide-positive 
admissions
Slide-positive 
deaths
SMA CM Ratio 
CM/SMA
Mean age of slide 
positive (years)
Mean age of slide 
negative (years)
Parasite 
prevalence
1990 51 939 34·21 12·36 0·87 2·02 0·54 0·27 2·3 2·15 0·16
1991 55 475 47·32 21·23 1·08 5·25 0·96 0·18 2·47 2·02 0·28
1992 59 012 39·13 21·96 0·93 3·97 ·· ·· 2·42 2·05 0·39
1993 62 548 38·37 18·16 0·67 3·09 0·42 0·13 2·4 1·93 0·35
1994 66 084 47·97 24·91 0·88 5·84 1·21 0·21 2·4 2·12 0·33
1995 69 620 41·67 19·52 0·49 3·3 0·95 0·29 2·37 1·95 0·34
1996 73 156 44·02 18·45 0·52 3·28 1·01 0·31 2·1 1·88 0·27
1997 76 692 44·7 20·95 1·02 4·75 1·51 0·32 2·37 1·87 0·28
1998 80 229 41·89 18·48 0·79 3·73 ·· ·· 2·46 1·93 0·31
1999 83 765 53·09 25·92 0·81 4·14 1·1 0·27 2·72 1·98 0·29
2000 87 301 50·3 21·75 0·63 2·78 1·17 0·42 2·66 1·98 0·24
2001 90 837 47·59 19·85 0·54 1·81 0·89 0·49 2·76 2·01 0·19
2002 94 195 41·59 17·17 0·64 2·04 2·05 1·01 2·93 2·02 0·19
2003 97 827 45·71 18·43 0·51 2·59 1·59 0·62 2·86 2·06 0·24
2004 101 747 39·86 11·27 0·33 1·52 1·07 0·7 2·78 2·05 0·13
2005 105 337 34·87 7·31 0·16 1·04 0·64 0·61 3·21 2·2 0·11
2006 108 121 36·27 5·76 0·16 0·75 0·58 0·78 3·44 2·05 0·07
2007 112 054 32·31 3·42 0·12 0·37 0·39 1·07 3·59 2·18 0·01
Data are incidence per 1000. Cerebral malaria (CM) incidence was not available for 1992 and 1998. SMA=severe malarial anaemia. 
Table 1: Epidemiological summary of malaria in children age less than 14 years, in Kiliﬁ , Kenya, 1990–2007
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Figure 1: Hospital admissions per 1000 children resident in the study area
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Before 1998, the ﬁ rst-line antimalarial therapy was 
chloroquine. Increases in resistance to chloroquine over 
several years prompted a national policy change to 
sulfadoxine–pyrimethamine as the ﬁ rst-line therapy 
in 1998.21 Shortly after the switch, a shopkeeper training 
programme was initiated in northern Kiliﬁ  to increase 
antimalarial access in the community through the 
informal retail sector.22 In September, 2006, artemether–
lumefantrine replaced sulfadoxine–pyrimethamine in 
government clinics and is oﬀ ered to paediatric patients, 
free of charge, through the public-health sector.23 
Data collection
The hospital keeps records of clinical examination, 
location of residence, laboratory investigations, discharge 
diagnoses, and outcome for each child admitted in a 
central database.24,25 A routine blood slide is taken on all 
admissions and is examined by microscopy for malaria 
parasites. Haemoglobin concentrations are also measured 
for all admissions. Clinical intake examination includes 
an assessment of the level of consciousness and children 
are given a Blantyre coma score.26 Blantyre coma scores 
are available for all children between 2002 and 2007 and 
for those admitted to the high-dependency unit 
between 1990 and 2001. Records from the high-dependency 
unit could not be located for the last 6 months of 1992, and 
children admitted to the high-dependency unit in 1998 
could not be matched to the ward registers, so these years 
were omitted from the analysis of severe disease. Only 
children who were resident in the study area at the time of 
admission were included in the analysis.
Hospitalised malaria was deﬁ ned as any admission 
with a positive blood ﬁ lm. Severe malarial anaemia was 
deﬁ ned as a parasite-positive blood ﬁ lm on intake and a 
haemoglobin concentration of less than 5 g/dL. Cerebral 
malaria was deﬁ ned as a parasite-positive blood ﬁ lm on 
intake and a Blantyre coma score of less than 3. The 
deﬁ nitions were not mutually exclusive. Although 
impaired consciousness might not be due to parasites in 
some patients, this is the most objective deﬁ nition of 
cerebral malaria and can be uniformly applied to all 
admissions. Studies and data collection methods were 
approved by the Kenya Medical Research Institute’s 
ethical review committee.
Parasite densities from children admitted to Kiliﬁ 
District Hospital for malaria and from children admitted 
because of trauma (taken as control individuals) were 
used to model the relation between parasite density and 
clinical disease. The method has been described 
previously.27 A logistic regression model was used where 
log(p)=a+bxτ, p is the probability of admission, 
x is the density of parasitaemia, and τ is the power 
function that maximises the likelihood estimation. The 
Mean incidence per 1000 MAF (95% CI)
All admissions Slide-positive 
admissions
1998–2003 45·4 19·7 0·61 (0·56–0·65)
2004–07 35·1 6·8 0·70 (0·66–0·74)
Diﬀ erence 10·3 12·9 ··
Expected diﬀ erence 
(95% CI)*
7·8 (7·2–8·4) ·· ··
*Expected diﬀ erence in all admissions is the change in slide-positive admissions 
multiplied by the malaria attributable fraction from the preceding years 
(ie, 12·9×0·61). MAF=malaria attributable fraction.
Table 2: Diﬀ erence in all admissions and slide-positive admissions before 
and after the decline in slide-positive admissions
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Figure 2: Annual parasite prevalence in patients admitted for trauma 
Bars are 95% CIs.
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Figure 3: Mean age in years of slide-positive and slide-negative hospital admissions by year
Bars are 95% CIs.
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coeﬃ  cient b in the logistic model can then be used to 
calculate the risk of malaria for each individual. The risks 
of a group of individuals are summed to estimate the 
proportion of the group with true malaria. The model 
was repeated in two time periods; several years before 
changes in incidence of slide-positive admissions 
(1998–2003) and the years after initial changes in 
incidence (2004–07). Conﬁ dence intervals were estimated 
by bootstrapping with 1000 iterations.
Analysis 
Population data and growth rate from the 1999 population 
and housing census were obtained from the Kenya 
National Bureau of Statistics for each location. The study 
area population was multiplied by the proportion of 
children under 14 years of age (46%, H Gatakaa Kenya 
Medical Research Institute–Wellcome Trust, personal 
communication). The number of children under 
14 in other years was estimated by assuming a 3·1% growth 
rate and extrapolating back wards and forwards from 1999. 
Annual incidence was calculated by dividing the total 
number of hospital events (admis sions, deaths, etc) by the 
total number of chil dren under 14 years of age resident in 
the study area for each year. 
Statistical analyses were done with Stata 9.0. Trends in 
incidence by year were investigated with linear regression. 
The residuals of linear regression of age on year showed 
slight deviations from normality, so trends were 
investigated with quintile regression. However, results 
did not diﬀ er between the two methods. Conﬁ dence 
intervals for parasite prevalence were calculated with a 
binomial distribution.
Role of the funding source
The sponsor of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
Between 1800 and 4400 children from the study area were 
admitted to the paediatric ward and had blood ﬁ lms 
examined for parasites each year (table 1). An initial 
increase in slide-positive admissions between 1990 
and 1991 reﬂ ects an increase in hospital use and all-cause 
admissions during that period (ﬁ gure 1). Between 1990 
and 2003, the incidence of admissions for malaria 
ﬂ uctuated with the total admissions, whereas the 
proportion of all admissions with parasites was stable 
at 40–50% (data not shown). No signiﬁ cant trend in 
incidence was apparent from 1990 to 2003 (p=0·68). 
In 2004, the incidence of hospital admissions for malaria 
began to fall (p=0·008 for 1990–2007). The incidence of 
slide-positive admissions in 2007 was less than a ﬁ fth of 
that in 2003 (table 1), and only 383 (11%) of 3620 
admissions were slide-positive.
Malaria attributable fractions calculated from logistic 
regression suggested that 61% of slide-positive 
admissions were attributable to malaria infection during 
1998–2003, just before changes in the incidence of 
slide-positive admissions (table 2). Because the mean 
incidence of admissions with positive slides fell by 12·9 
per 1000 by 2004–2007, an attributable fraction of 61% 
would predict that overall incidence of admissions 
would fall by 7·8 per 1000. In fact, the overall drop in 
admissions, 10·3 per 1000, was slightly higher than this 
prediction (table 2). 
Between 130 and 350 children from the study area were 
admitted each year for accidents such as fractures, snake 
bites, burns, and poisoning. The mean age of this group 
is 4·0 years (95% CI 3·85–4·07). Parasitaemia among 
these children is unrelated to the cause for their 
admission and is therefore expected to reﬂ ect exposure to 
infection in the community. Parasite prevalence decreased 
from 1992 to 2007 (p<0·0001; ﬁ gure 2) indicating a 
reduction in exposure to infection among children across 
the hospital catchment area. 
Over the surveillance period, the mean age of 
slide-positive admissions rose signiﬁ cantly (p<0·0001), 
but the mean age for slide-negative admissions remained 
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Figure 4: Annual incidence (A) and ratio (B) of cerebral malaria and severe malarial anaemia 
Data for cerebral malaria were unavailable in 1992 and 1998. SMA=severe malarial anaemia. CM=cerebral malaria.
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stable (table 1; ﬁ gure 3). The increase in age of 
slide-positive patients was incrementally distributed over 
the last 10 years or so.
Annually, a mean of 28% of slide positive admissions 
ﬁ t the criteria for severe disease, either severe malarial 
anaemia (haemoglobin <5 g/dL) or cerebral malaria 
(Blantyre coma score <3). At the beginning of the 
surveillance period, the number of cases of severe 
malarial anaemia outnumbered those of cerebral malaria 
by more than four to one (table 1). The incidence of 
cerebral malaria increased gradually from 1990 to 2002, 
whereas the incidence of severe malarial anaemia began 
to decrease in 1997 (ﬁ gure 4). In 2002, the incidence of 
cerebral malaria equalled that of severe malarial anaemia. 
When numbers of slide-positive admissions began to fall 
in 2004, admissions of both forms of severe malaria 
decreased in parallel, but the ratio of cerebral malaria to 
severe malarial anaemia continues to rise (ﬁ gure 4). 
In 2007, the incidence of cerebral malaria barely exceeded 
that of severe malarial anaemia. 
The mean age of children with severe malarial anaemia 
was 2·1 years and increased slightly but not signiﬁ cantly 
over the 18 years (2·5 years). The mean age for cerebral 
malaria remained constant (3·1 years) and was 
signiﬁ cantly higher than that for severe malarial anaemia 
in each year (p<0·005 for all 16 comparisons). The 
incidence of severe malarial anaemia peaked in 6 month 
olds, whereas incidence of cerebral malaria peaked at 
2 years of age, leading to distinct age distributions for 
each syndrome (ﬁ gure 5). 
Mortality among slide-positive admissions ﬂ uctuated 
from year to year (ﬁ gure 6), although there was a small 
but signiﬁ cant decrease over the surveillance period 
(p<0·0001). As with the incidence of slide-positive 
admissions, no signiﬁ cant trend in mortality of 
slide-positive admissions was detected before 2003. 
However, in 2004 malaria mortality was lower than for 
any of the previous 14 years (table 1). The number of 
deaths continued to decrease from 2004 to 2007 (table 1) 
in parallel with the decrease in slide-positive admissions. 
In 2007, there were fewer than 15 deaths of children who 
were slide positive, compared with 78 in 1997.
Overall, case-fatality for non-severe malaria admissions 
(ie, slide positive but neither severe malarial anaemia nor 
cerebral malaria) was low: 2·1% (400/18 829) compared 
with 8·3% (3176/38 100) for slide-negative admissions. 
The case fatality for both forms of severe disease was 
higher than for non-severe slide-positive admissions: 
5·9% (214/3652) for severe malarial anaemia and 14·0% 
(167/1194) for cerebral malaria. The case fatality for 
non-severe slide-positive admissions fell signiﬁ cantly with 
time from 6·5% in 1990 to 1·3% in 2007 (p<0.0001), 
whereas there was no signiﬁ cant trend in case fatality of 
cerebral malaria or severe malarial anaemia.
Infants younger than 6 months were at the greatest 
risk of death (5·9%), but that risk fell to 3·8% by age 1 year. 
Case fatality remained stable in early childhood (4·2% in 
children age 1–5 years), and decreased slightly 
in children age 6–8 years (2·7%), before increasing again 
in children age 9–14 years (4·1%).
Discussion
Transmission of malaria has been changing for over 
10 years, as evidenced by declining prevalence of 
parasitaemia among trauma admissions (an indicator 
of parasite prevalence in the community), increasing 
mean age of malaria admissions, and shifting 
presentation of severe disease; however, the absolute 
incidence of malaria disease presenting to hospital only 
began to change 4–5 years ago. Once this change began, 
the eﬀ ect has been substantial as evidenced by a 
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Figure 5: Age distributions for children admitted with severe malarial anaemia (A) and cerebral malaria (B)
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Figure 6: Mortality of slide-positive cases per 10 000 children resident in the study area 
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reduction in deaths from malaria of more than 75%. 
The fall in transmission is not speciﬁ c to Kiliﬁ  and 
seems to involve the entire coastal region of Kenya.14 
Our results are consistent with comparisons between 
multiple sites2,3,9 and provide further evidence that 
reduction of trans mission leads to a change in pattern 
of severe disease but might not lead to immediate 
reductions in disease burden. The threshold parasite 
prevalence of 20%, above which disease incidence 
remained constant and below which incidence fell 
sharply, was identical to that predicted in studies across 
multiple sites.9 
The pathology of severe disease is partly dependent 
on the age of individuals independent of previous 
exposure.28,29 In children age less than 2 years, severe 
malaria typically manifests as life-threatening anaemia. 
In older children, there is an increased risk of cerebral 
malaria, characterised by impaired consciousness, 
seizures, and coma.30 In previous studies, possible 
diﬀ erences between host and parasite populations 
could not be excluded as potential confounders in the 
diﬀ erences observed between sites. In Kiliﬁ , increasing 
mean age of patients who were slide positive on 
admission over the past 10 years was accompanied by 
an increase in the proportion of severe disease 
presenting as cerebral malaria. Although the overall 
mean age of hospital admissions for malaria increased, 
the mean age of children with severe malarial anaemia 
was consistently lower than that of children with 
cerebral malaria. This ﬁ nding supports the hypothesis 
that the pathology of severe malaria is related to 
intrinsic factors of host age rather than only to extrinsic 
factors, such as parasite genetics or transmission 
intensity. 
In multisite comparisons, low transmission was 
associated with higher mean age of hospitalisation and, 
as a result, a higher proportion of cerebral malaria than 
found in areas of high transmission.2,7,8 The case fatality 
of hospitalised clinical malaria has been reported to 
increase with age after the ﬁ rst year of life,8,9 partly 
because of the high case fatality of cerebral malaria 
compared with that of severe malarial anaemia.8,31,32 If 
the total number of patients hospitalised with clinical 
malaria remains constant, or even increases, as 
transmission decreases from high to intermediate 
levels, then increasing age at hospitalisation might lead 
to higher incidence of cerebral malaria and malaria 
mortality.11 Our study did not support this scenario, 
consistent with results from shorter periods of 
observation after trials with insecticide-treated 
bednets.33,34 Although the mean age of severe and 
uncomplicated malaria rose, and the proportion of 
cerebral malaria increased as predicted, we did not ﬁ nd 
increasing overall mortality or severe morbidity as a 
result. A small increase in the number of deaths in 
patients with cerebral malaria was oﬀ set by a decrease 
in incidence of severe malarial anaemia and the 
improved survival of moderate malaria admissions. 
Although incidence of cerebral malaria increased 
between 1990 and 2002, this presentation remains 
rare. 
Older children exposed to higher levels of transmission 
in early life might have a lower incidence of cerebral 
malaria than those who grow up in an area of low, stable 
endemicity. Indeed, by contrast with other studies,8,9 
case fatality for hospitalised malaria was lower in older 
children than in younger children in our study. The 
diﬀ erence in the relation between age and case fatality 
indicates greater heterogeneity of exposure in children 
born during the surveillance period, than in earlier 
studies with observations made over shorter time 
intervals in several sites. More generally, our results 
describe a community undergoing a gradual change in 
transmission and may be diﬀ erent than those generated 
by an abrupt change in exposure as a result of 
widespread deployment of a highly eﬀ ective intervention 
followed by a gradual equilibration at lower 
transmission. The incidence of cerebral malaria might 
increase as children with less exposure grow up and 
experience episodes of severe disease. However, on the 
basis of current trends, the proportion of severe disease 
presenting as cerebral malaria will probably increase, 
but the incidence will likely continue to fall.
The reduction in all hospital admissions was small 
compared with the reduction in slide-positive 
admissions, indicating that some slide-positive 
admissions are coincidental coinfections. The malaria 
attributable fraction calculations conﬁ rmed this. After 
adjusting for coincidental parasitaemias, all admissions 
decreased more than would be expected. The 
attributable-fraction model might underestimate the 
true proportion of malaria cases or infection might 
increase suscepti bility to other disease and reduction of 
infection could reduce total admissions by more than 
just the true malaria cases.
The reasons for the changing pattern of malaria 
epidemiology and declining disease burden are most 
likely multifactorial. Bednet distribution in parts of 
northern Kiliﬁ  in the early 1990s19 could have initially 
contributed to the fall in transmission in that area.15 
Bednet use 5 years later remained high in the bednet 
trial area (69%), although most nets were untreated and 
in bad repair.35 Bednet coverage in most of the catchment 
population was much lower; the 5% coverage reported 
in southern Kiliﬁ 20 is unlikely to have lowered 
transmission. The number of insecticide-treated nets in 
the district at the time of the greatest change in disease 
burden was estimated to be less than one for every 
ten people.14 Coverage increased to about one for every 
two people between 2005 and 2007, but this was after 
the steep fall in malaria admissions. Increases in the 
mean age of children with malaria, indicating reduced 
exposure to infection, seem to be contemporary with the 
replacement of chloroquine with sulfadoxine–
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pyrimethamine as the ﬁ rst-line therapy 10 years ago. 
The widespread use of an eﬀ ective, longlasting 
antimalarial possibly contributed to the reduction in 
transmission. What seems clear is that the substantial 
changes in the epidemiology and burden of disease 
observed in Kiliﬁ  began before large-scale distribution 
of insecticide-treated bednets and availability of 
artemisinin-combination therapies. Other areas in east 
Africa have described similar reductions in burden of 
disease correlated to the scale-up of control eﬀ orts,36–38 
but this does not seem to be the case in Kiliﬁ . Although 
eﬀ ective treatment and prevention will play a crucial 
part in maintaining and further reducing the burden of 
malaria in Kiliﬁ , the initial cause of the reduction 
remains unknown.
Other external factors unrelated to speciﬁ c malaria 
interventions might have changed over the 18 years of 
surveillance and aﬀ ected the presentation of disease at 
the hospital. These factors include those that aﬀ ect the 
risk of infection, reﬂ ected in declining parasite 
prevalence observed here, as well as factors that aﬀ ect 
the probability of presenting at the hospital with clinical 
disease. Agriculture practices, economic development, 
housing construction, and environmental management 
of breeding sites for mosquitoes, among others, likely 
changed over time and might have contributed to the 
reduced risk of infection in the community. Changing 
rates of hospital use due to expanding transport 
networks, user fees, the eﬀ ectiveness of treatment at 
the primary care level, or changes in referral practices, 
could have inﬂ uenced the probability of presenting at 
the hospital in either direction. Overall, there is evidence 
for gradually increasing use of hospitals, although 
changes have been small. Slight increases in hospital 
use could have increased the apparent incidence of 
malaria, leading to an underestimate of the reductions 
in malaria incidence. Although presentation with 
trauma might be inﬂ uenced by factors aﬀ ecting hospital 
use, parasite prevalence among those patients would 
not be. In other words, prevalence in trauma patients is 
likely to reﬂ ect transmission independent of external 
factors that aﬀ ect disease presentation.
Observations from 18 years of longitudinal surveillance 
show non-linear relations between incidence and 
presentation of disease, age, and mortality. The changes 
in the pattern of clinical disease are consistent with 
long-term, sustained reductions in transmission. 
Signiﬁ cant increases in the mean age of slide-positive 
hospital admissions, and a rise in the proportion of 
cerebral malaria preceded changes in the overall 
incidence of disease. Continued surveillance is needed to 
describe changes in the burden of disease among those 
children growing up with much less exposure than those 
born only 5 years or 10 years ago. Emphasis on use of 
insecticide-treated bednets, early treatment, and other 
control measures must be increased to maintain 
reductions in disease burden and prevent a potential 
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resurgence of malaria in a population with far less 
immunity than before.
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